ROS1ders in the News

16-May-2016: “Miracle drug trial saved woman’s life,” (9News, Denver NBC News affiliate)

06-Feb-2017: Deadly, rare lung cancer finds big foe: Patients with little to lose (San Francisco Business Times)

23-May-2017: ROS1+ Cancer Patients Partner to Increase Research (National Cancer Institute’s Insights and Innovations Blog)

06-Aug-2017: Cancer front line / Genetic analysis enables personalized cancer treatment (Yomiuri Shimbun, English version in The Japan News)

07-Aug-2017: Cancer front line / Cancer patients seek information on gene mutations (Yomiuri Shimbun, English version in The Japan News)

07-Aug-2017: Japan cancer patients’ online quest for answers (Yomiuri Shimbun, English version in The Japan News)

15-Aug-2017: ALCMI, Champions Oncology, and ROS1ders to launch clinical study (Bonnie J. Addario Lung Cancer Foundation)

15-Aug-2017: ROS1 cancer patients set out to create disease models (Fierce Biotech)

7-Sep-2017: Patient Advocacy Strategies Evolve as Genomic Advances Change Understanding of Cancer (Genome Web)

Feb-2017: Women with rare, deadly lung cancer aid in search for next cure (San Francisco Business Times)

17-Apr-2018: Global ROS1 initiative: A patient-researcher collaboration targeting ROS1 cancer (EurekAlert by American Association for the Advancement of Science)

02-May-2018: The ‘Ross-Wonders’, Cancer’s New Superheroes (Forbes)

21-May-2018: Pazienti con la mutazione Ros-1, supereroi in cerca di una cura (Republica Italy)

05-Jun-2018: Motivated, Engaged, and Organized: The New Molecular Cohorts of Lung Cancer (IASLC News)

18-Jun-2018: Non-Small Cell Lung Cancer Survivor Becomes High-Profile Advocate for ROS1 Testing (ThermoFisher Scientific)



Updated 23-Jul-2018